Compounds > abiraterone
Page last updated: 2024-09-04

abiraterone and Hypertension

abiraterone has been researched along with Hypertension in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Abadie-Lacourtoisie, S; Berdah, JF; Berthold, D; Bossi, A; Calabro, F; Carles, J; Chand-Fouche, ME; El Kouri, C; Escande, A; Fizazi, K; Fléchon, A; Foulon, S; Freixa, SV; Gravis, G; Hasbini, A; Jamaluddin, M; Kacso, G; Laguerre, B; Latorzeff, I; Magne, N; Martin, E; McDermott, R; Mourey, L; Priou, F; Rieger, I; Ronchin, P; Rosello, A; Roubaud, G; Schlurmann, F; Silva, M; Supiot, S; Thiery-Vuillemin, A; Tombal, B1
Addison, D; Baumann, BC; Calaway, AC; Campbell, CM; Cullen, J; Desai, NR; Fradley, MG; Garcia, JA; Ghosh, AK; Guha, A; Lenihan, DJ; Ponsky, L; Reimers, MA; Weintraub, N; Zhang, KW1
Artibani, W; Bimbatti, D; Bria, E; Brunelli, M; Ciccarese, C; Fantinel, E; Iacovelli, R; Mazzarotto, R; Muraglia, A; Porcaro, AB; Romano, M; Siracusano, S; Tortora, G1
Andresen-Daniil, C; Attard, G; Borre, M; Gurney, H; Kalleda, R; Loriot, Y; Pham, T; Taplin, ME1

Reviews

1 review(s) available for abiraterone and Hypertension

ArticleYear
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.
    Clinical genitourinary cancer, 2018, Volume: 16, Issue:3

    Topics: Androstenes; Benzamides; Cardiovascular Diseases; Disease-Free Survival; Humans; Hypertension; Incidence; Male; Nitriles; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic

2018

Trials

2 trial(s) available for abiraterone and Hypertension

ArticleYear
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
    Lancet (London, England), 2022, 04-30, Volume: 399, Issue:10336

    Topics: Androgen Antagonists; Androgens; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Castration; Docetaxel; Female; Humans; Hypertension; Male; Prednisone; Prostatic Neoplasms

2022
Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 09-01, Volume: 36, Issue:25

    Topics: Androstenes; Antineoplastic Agents; Benzamides; Double-Blind Method; Drug Resistance, Neoplasm; Humans; Hypertension; Liver; Male; Nitriles; Phenylthiohydantoin; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2018

Other Studies

1 other study(ies) available for abiraterone and Hypertension

ArticleYear
Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS).
    The Journal of urology, 2021, Volume: 206, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cross-Sectional Studies; Databases, Factual; Gonadotropin-Releasing Hormone; Heart Failure; Humans; Hypertension; Male; Middle Aged; Pharmacovigilance; Prostatic Neoplasms; Retrospective Studies; United States; United States Food and Drug Administration; Young Adult

2021